chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Red and warm and swollen; A little sore; Red and warm and swollen; Kind of firm; Red and warm and swollen; I just started some itching to my left arm around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Red and warm and swollen), VACCINATION SITE PRURITUS (I just started some itching to my left arm around the injection site), VACCINATION SITE INDURATION (Kind of firm), VACCINATION SITE ERYTHEMA (Red and warm and swollen) and VACCINATION SITE SWELLING (Red and warm and swollen) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (I just started some itching to my left arm around the injection site). On 12-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Red and warm and swollen), VACCINATION SITE INDURATION (Kind of firm), VACCINATION SITE ERYTHEMA (Red and warm and swollen) and VACCINATION SITE PAIN (A little sore). On an unknown date, the patient experienced VACCINATION SITE SWELLING (Red and warm and swollen). At the time of the report, VACCINATION SITE WARMTH (Red and warm and swollen), VACCINATION SITE PRURITUS (I just started some itching to my left arm around the injection site), VACCINATION SITE INDURATION (Kind of firm), VACCINATION SITE ERYTHEMA (Red and warm and swollen), VACCINATION SITE SWELLING (Red and warm and swollen) and VACCINATION SITE PAIN (A little sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported  No treatment information was provided
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Red and warm and swollen; A little sore; Red and warm and swollen; Kind of firm; Red and warm and swollen; I just started some itching to my left arm around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Red and warm and swollen), VACCINATION SITE PRURITUS (I just started some itching to my left arm around the injection site), VACCINATION SITE INDURATION (Kind of firm), VACCINATION SITE ERYTHEMA (Red and warm and swollen) and VACCINATION SITE SWELLING (Red and warm and swollen) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (I just started some itching to my left arm around the injection site). On 12-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Red and warm and swollen), VACCINATION SITE INDURATION (Kind of firm), VACCINATION SITE ERYTHEMA (Red and warm and swollen) and VACCINATION SITE PAIN (A little sore). On an unknown date, the patient experienced VACCINATION SITE SWELLING (Red and warm and swollen). At the time of the report, VACCINATION SITE WARMTH (Red and warm and swollen), VACCINATION SITE PRURITUS (I just started some itching to my left arm around the injection site), VACCINATION SITE INDURATION (Kind of firm), VACCINATION SITE ERYTHEMA (Red and warm and swollen), VACCINATION SITE SWELLING (Red and warm and swollen) and VACCINATION SITE PAIN (A little sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported  No treatment information was provided
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Dry skin, Vaccination site rash, Vaccination site warmth
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash), VACCINATION SITE WARMTH (Warm) and DRY SKIN (Feels little dry) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE RASH (rash). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Warm) and DRY SKIN (Feels little dry). At the time of the report, VACCINATION SITE RASH (rash), VACCINATION SITE WARMTH (Warm) and DRY SKIN (Feels little dry) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication include medication for Blood pressure, Cholesterol, Anxiety and Calcium suppliments.  No treatment information was provided
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Peripheral swelling
Clinical narrative: arm is still getting bigger and bigger; hot; red; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm is still getting bigger and bigger), FEELING HOT (hot) and ERYTHEMA (red) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced PERIPHERAL SWELLING (arm is still getting bigger and bigger), FEELING HOT (hot) and ERYTHEMA (red). At the time of the report, PERIPHERAL SWELLING (arm is still getting bigger and bigger), FEELING HOT (hot) and ERYTHEMA (red) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment medications were not provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: Aches; Pain in her arm/arm felt very sore; Fever of 100F; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Aches), VACCINATION SITE PAIN (Pain in her arm/arm felt very sore), PYREXIA (Fever of 100F) and CHILLS (Chills) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included HYDROCODONE for Pain.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced MYALGIA (Aches), VACCINATION SITE PAIN (Pain in her arm/arm felt very sore), PYREXIA (Fever of 100F) and CHILLS (Chills). At the time of the report, MYALGIA (Aches), VACCINATION SITE PAIN (Pain in her arm/arm felt very sore), PYREXIA (Fever of 100F) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Impaired work ability, Periarthritis, Vaccination site movement impairment, Vaccination site pain
Clinical narrative: Trouble lifting arm and doing anything with it, hard to move; Incapacity; Frozen shoulder; Pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Trouble lifting arm and doing anything with it, hard to move), IMPAIRED WORK ABILITY (Incapacity), PERIARTHRITIS (Frozen shoulder) and VACCINATION SITE PAIN (Pain) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Cholesterol. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Trouble lifting arm and doing anything with it, hard to move), IMPAIRED WORK ABILITY (Incapacity), PERIARTHRITIS (Frozen shoulder) and VACCINATION SITE PAIN (Pain). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Trouble lifting arm and doing anything with it, hard to move), IMPAIRED WORK ABILITY (Incapacity), PERIARTHRITIS (Frozen shoulder) and VACCINATION SITE PAIN (Pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication include Medicine for high blood pressure and cholesterol.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: arm soreness/Arm being sore to the touch; fatigue; Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), PAIN IN EXTREMITY (arm soreness/Arm being sore to the touch) and FATIGUE (fatigue) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M204) for COVID-19 vaccination.     The patient's past medical history included Arthritis.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness) and FATIGUE (fatigue). On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm soreness/Arm being sore to the touch). The patient was treated with NAPROXEN (NAPROXIN [NAPROXEN]) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm soreness) and FATIGUE (fatigue) had resolved and PAIN IN EXTREMITY (arm soreness/Arm being sore to the touch) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported. treatment information also include ice pack.   Reporter did not allow further contact
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: "really itchy"; large red ring rash; Left arm became sore,tender and burning; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS ("really itchy"), VACCINATION SITE PAIN (Left arm became sore,tender and burning) and VACCINATION SITE ERYTHEMA (large red ring rash) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included Acid reflux (esophageal) and Hypertension. Previously administered products included for an unreported indication: shingles vaccine and FLU. Concurrent medical conditions included Diabetes. Concomitant products included METOPROLOL, INDAPAMIDE, LOSARTAN, FAMOTIDINE and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication, FISH OIL.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (Left arm became sore,tender and burning). On 10-Feb-2021, the patient experienced VACCINATION SITE PRURITUS ("really itchy") and VACCINATION SITE ERYTHEMA (large red ring rash). At the time of the report, VACCINATION SITE PRURITUS ("really itchy"), VACCINATION SITE PAIN (Left arm became sore,tender and burning) and VACCINATION SITE ERYTHEMA (large red ring rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment information include cold compress
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Feeling hot, Insomnia, Myalgia, Neck pain
Clinical narrative: neck and back hurt; she felt like a train wreck; husband said she felt warm; in so much pain it was hard to sleep; ached all over; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (neck and back hurt), FEELING ABNORMAL (she felt like a train wreck), FEELING HOT (husband said she felt warm), INSOMNIA (in so much pain it was hard to sleep) and MYALGIA (ached all over) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 immunisation.     Concomitant products included LOSARTAN and CALCIUM PANTOTHENATE, FOLIC ACID, VITAMINS NOS (MULTI-VITAMINS VITAFIT) for an unknown indication.    On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced NECK PAIN (neck and back hurt), FEELING ABNORMAL (she felt like a train wreck), FEELING HOT (husband said she felt warm), INSOMNIA (in so much pain it was hard to sleep) and MYALGIA (ached all over). At the time of the report, NECK PAIN (neck and back hurt), FEELING ABNORMAL (she felt like a train wreck), FEELING HOT (husband said she felt warm), INSOMNIA (in so much pain it was hard to sleep) and MYALGIA (ached all over) was resolving.            No treatment medication details were provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Oropharyngeal pain, Vaccination site pain
Clinical narrative: Sore throat; Chills; Tired; Sore arm from first injection; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), CHILLS (Chills), FATIGUE (Tired) and VACCINATION SITE PAIN (Sore arm from first injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Sore throat), CHILLS (Chills), FATIGUE (Tired) and VACCINATION SITE PAIN (Sore arm from first injection). At the time of the report, OROPHARYNGEAL PAIN (Sore throat), CHILLS (Chills), FATIGUE (Tired) and VACCINATION SITE PAIN (Sore arm from first injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication use was not reported.   Treatment included Claritin and an unspecified antibiotic.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Cheilitis, Chills, Headache, Pyrexia
Clinical narrative: Rash on lip; Rash on face, rash on left eye lids, rash on nose; Chills; High Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHEILITIS (Rash on lip), RASH (Rash on face, rash on left eye lids, rash on nose), CHILLS (Chills), PYREXIA (High Fever) and HEADACHE (Headache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concurrent medical conditions included Herpes simplex.    On 06-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (High Fever) and HEADACHE (Headache). On 07-Feb-2021, the patient experienced CHEILITIS (Rash on lip) and RASH (Rash on face, rash on left eye lids, rash on nose). At the time of the report, CHEILITIS (Rash on lip), RASH (Rash on face, rash on left eye lids, rash on nose), CHILLS (Chills), PYREXIA (High Fever) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Feb-2021, Body temperature: high (High) High Fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on lip; Rash on face, rash on left eye lids, rash on nose; Chills; High Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHEILITIS (Rash on lip), RASH (Rash on face, rash on left eye lids, rash on nose), CHILLS (Chills), PYREXIA (High Fever) and HEADACHE (Headache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concurrent medical conditions included Herpes simplex.    On 06-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (High Fever) and HEADACHE (Headache). On 07-Feb-2021, the patient experienced CHEILITIS (Rash on lip) and RASH (Rash on face, rash on left eye lids, rash on nose). At the time of the report, CHEILITIS (Rash on lip), RASH (Rash on face, rash on left eye lids, rash on nose), CHILLS (Chills), PYREXIA (High Fever) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Feb-2021, Body temperature: high (High) High Fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Oropharyngeal pain
Clinical narrative: Uncomfortable; throat is hurting, sore throat; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Uncomfortable) and OROPHARYNGEAL PAIN (throat is hurting, sore throat) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced FEELING ABNORMAL (Uncomfortable) and OROPHARYNGEAL PAIN (throat is hurting, sore throat). At the time of the report, FEELING ABNORMAL (Uncomfortable) and OROPHARYNGEAL PAIN (throat is hurting, sore throat) outcome was unknown.            The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site discolouration, Vaccination site erythema, Vaccination site induration, Vaccination site pain
Clinical narrative: hard red lump, hot at the injection site; hard red lump, hot at the injection site; pain; headache; redness around edges, purple at injection site with another ring like a bulls eye; redness around edges, purple at injection site with another ring like a bulls eye; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hard red lump, hot at the injection site), VACCINATION SITE INDURATION (hard red lump, hot at the injection site), VACCINATION SITE DISCOLOURATION (redness around edges, purple at injection site with another ring like a bulls eye), VACCINATION SITE PAIN (pain) and VACCINATION SITE ERYTHEMA (redness around edges, purple at injection site with another ring like a bulls eye) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Headache.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE DISCOLOURATION (redness around edges, purple at injection site with another ring like a bulls eye) and VACCINATION SITE ERYTHEMA (redness around edges, purple at injection site with another ring like a bulls eye). On an unknown date, the patient experienced VACCINATION SITE WARMTH (hard red lump, hot at the injection site), VACCINATION SITE INDURATION (hard red lump, hot at the injection site), VACCINATION SITE PAIN (pain) and HEADACHE (headache). At the time of the report, VACCINATION SITE WARMTH (hard red lump, hot at the injection site), VACCINATION SITE INDURATION (hard red lump, hot at the injection site) and VACCINATION SITE PAIN (pain) had resolved and VACCINATION SITE DISCOLOURATION (redness around edges, purple at injection site with another ring like a bulls eye), VACCINATION SITE ERYTHEMA (redness around edges, purple at injection site with another ring like a bulls eye) and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported  No treatment information was provided
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: hard red lump, hot at the injection site; hard red lump, hot at the injection site; pain; headache; redness around edges, purple at injection site with another ring like a bulls eye; redness around edges, purple at injection site with another ring like a bulls eye; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hard red lump, hot at the injection site), VACCINATION SITE INDURATION (hard red lump, hot at the injection site), VACCINATION SITE DISCOLOURATION (redness around edges, purple at injection site with another ring like a bulls eye), VACCINATION SITE PAIN (pain) and VACCINATION SITE ERYTHEMA (redness around edges, purple at injection site with another ring like a bulls eye) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Headache.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE DISCOLOURATION (redness around edges, purple at injection site with another ring like a bulls eye) and VACCINATION SITE ERYTHEMA (redness around edges, purple at injection site with another ring like a bulls eye). On an unknown date, the patient experienced VACCINATION SITE WARMTH (hard red lump, hot at the injection site), VACCINATION SITE INDURATION (hard red lump, hot at the injection site), VACCINATION SITE PAIN (pain) and HEADACHE (headache). At the time of the report, VACCINATION SITE WARMTH (hard red lump, hot at the injection site), VACCINATION SITE INDURATION (hard red lump, hot at the injection site) and VACCINATION SITE PAIN (pain) had resolved and VACCINATION SITE DISCOLOURATION (redness around edges, purple at injection site with another ring like a bulls eye), VACCINATION SITE ERYTHEMA (redness around edges, purple at injection site with another ring like a bulls eye) and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported  No treatment information was provided
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Warm to the touch; Itching; Swollen like a knot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE PRURITUS (Itching) and VACCINATION SITE SWELLING (Swollen like a knot) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE PRURITUS (Itching) and VACCINATION SITE SWELLING (Swollen like a knot). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE PRURITUS (Itching) and VACCINATION SITE SWELLING (Swollen like a knot) outcome was unknown.            The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Concomitant product use was not provided by the reporter.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Headache.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: a sore arm; a slight headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a sore arm) and HEADACHE (a slight headache) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (a sore arm) and HEADACHE (a slight headache). On 14-Jan-2021, PAIN IN EXTREMITY (a sore arm) had resolved. On 15-Jan-2021, HEADACHE (a slight headache) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: Followup received on 13-Apr-2021. Contact details was updated(Email)
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Body temperature, Chills, Decreased appetite, Dizziness
Clinical narrative: Dizziness; loss of taste; Loss of appetite; Muscle aches; Headaches; Fever of 101.4; Shaking chills; This spontaneous case was reported by a physician and describes the occurrence of DIZZINESS (Dizziness), AGEUSIA (loss of taste), DECREASED APPETITE (Loss of appetite), MYALGIA (Muscle aches) and HEADACHE (Headaches) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced DIZZINESS (Dizziness), AGEUSIA (loss of taste), DECREASED APPETITE (Loss of appetite), MYALGIA (Muscle aches), HEADACHE (Headaches), PYREXIA (Fever of 101.4) and CHILLS (Shaking chills). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizziness), MYALGIA (Muscle aches), HEADACHE (Headaches) and CHILLS (Shaking chills) had resolved and AGEUSIA (loss of taste), DECREASED APPETITE (Loss of appetite) and PYREXIA (Fever of 101.4) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Feb-2021, Body temperature: 101.4 (Inconclusive) Fever of 101.4. On an unknown date, Body temperature: 98.6 (Inconclusive) temp at 98.6.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Concomitant product use was not provided by the reporter.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: Dizziness; loss of taste; Loss of appetite; Muscle aches; Headaches; Fever of 101.4; Shaking chills; This spontaneous case was reported by a physician and describes the occurrence of DIZZINESS (Dizziness), AGEUSIA (loss of taste), DECREASED APPETITE (Loss of appetite), MYALGIA (Muscle aches) and HEADACHE (Headaches) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced DIZZINESS (Dizziness), AGEUSIA (loss of taste), DECREASED APPETITE (Loss of appetite), MYALGIA (Muscle aches), HEADACHE (Headaches), PYREXIA (Fever of 101.4) and CHILLS (Shaking chills). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizziness), MYALGIA (Muscle aches), HEADACHE (Headaches) and CHILLS (Shaking chills) had resolved and AGEUSIA (loss of taste), DECREASED APPETITE (Loss of appetite) and PYREXIA (Fever of 101.4) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Feb-2021, Body temperature: 101.4 (Inconclusive) Fever of 101.4. On an unknown date, Body temperature: 98.6 (Inconclusive) temp at 98.6.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Concomitant product use was not provided by the reporter.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Knuckle pads, Pain in extremity
Clinical narrative: knuckle of fingers starting flaring up; SORE ARM; A spontaneous report was received from a consumer concerning a 70-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events sore arm, knuckle of the fingers started flaring up.  The patient's medical history include arthritis. No relevant concomitant medications were reported.  On 11 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 12 Feb 2021, the patient experienced the event sore arm . On 14 Feb 2021, the patient experienced the event knuckle of the fingers started flaring up.  Treatment details included Tylenol.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event, sore arm was considered recovered/ resolved, and the outcome of the event-  knuckle of the fingers started flaring up was unknown.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Lethargy
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Felt lethargic and tired) and FATIGUE (Felt lethargic and tired) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and unknown) for COVID-19 vaccination.     Concomitant products included CALCIUM PANTOTHENATE, FOLIC ACID, VITAMINS NOS (MULTI-VITAMINS VITAFIT) for an unknown indication.   On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced LETHARGY (Felt lethargic and tired). On an unknown date, the patient experienced FATIGUE (Felt lethargic and tired). At the time of the report, LETHARGY (Felt lethargic and tired) and FATIGUE (Felt lethargic and tired) outcome was unknown.            No treatment information were reported. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chills, Feeling abnormal, Headache
Clinical narrative: Weak as a cat; feeling very horrible and as bad as when he had the virus in April; Pounding headaches; Chills; Fever; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weak as a cat), FEELING ABNORMAL (feeling very horrible and as bad as when he had the virus in April), HEADACHE (Pounding headaches), CHILLS (Chills) and PYREXIA (Fever) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included SARS-CoV-2 infection (he felt when he had the virus in April of last year) in April 2020.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced ASTHENIA (Weak as a cat), FEELING ABNORMAL (feeling very horrible and as bad as when he had the virus in April), HEADACHE (Pounding headaches), CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Muscle aches). At the time of the report, ASTHENIA (Weak as a cat), FEELING ABNORMAL (feeling very horrible and as bad as when he had the virus in April), HEADACHE (Pounding headaches), CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Muscle aches) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Body temperature: inconclusive (Inconclusive) Fever.         The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Suspect drug details, event outcomes were updated.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Weak as a cat; feeling very horrible and as bad as when he had the virus in April; Pounding headaches; Chills; Fever; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weak as a cat), FEELING ABNORMAL (feeling very horrible and as bad as when he had the virus in April), HEADACHE (Pounding headaches), CHILLS (Chills) and PYREXIA (Fever) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included SARS-CoV-2 infection (he felt when he had the virus in April of last year) in April 2020.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced ASTHENIA (Weak as a cat), FEELING ABNORMAL (feeling very horrible and as bad as when he had the virus in April), HEADACHE (Pounding headaches), CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Muscle aches). At the time of the report, ASTHENIA (Weak as a cat), FEELING ABNORMAL (feeling very horrible and as bad as when he had the virus in April), HEADACHE (Pounding headaches), CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Muscle aches) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Body temperature: inconclusive (Inconclusive) Fever.         The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Suspect drug details, event outcomes were updated.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Type IV hypersensitivity reaction, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Delayed reaction; Itching around the injection site; Redness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (Delayed reaction), VACCINATION SITE PRURITUS (Itching around the injection site) and VACCINATION SITE ERYTHEMA (Redness around the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (Delayed reaction), VACCINATION SITE PRURITUS (Itching around the injection site) and VACCINATION SITE ERYTHEMA (Redness around the injection site). At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (Delayed reaction), VACCINATION SITE PRURITUS (Itching around the injection site) and VACCINATION SITE ERYTHEMA (Redness around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; lightheaded; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and DIZZINESS (lightheaded) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced DIZZINESS (Dizziness) and DIZZINESS (lightheaded). At the time of the report, DIZZINESS (Dizziness) and DIZZINESS (lightheaded) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: It has been itching all day; Silver dollar red area where I was given the shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (It has been itching all day) and VACCINATION SITE ERYTHEMA (Silver dollar red area where I was given the shot) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (It has been itching all day) and VACCINATION SITE ERYTHEMA (Silver dollar red area where I was given the shot). At the time of the report, VACCINATION SITE PRURITUS (It has been itching all day) and VACCINATION SITE ERYTHEMA (Silver dollar red area where I was given the shot) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Decreased appetite, Diarrhoea, Heart rate, Palpitations
Clinical narrative: Covid symptoms; Diarrhea; Red rash; Fever of 101.6; Fast heart beat/Pulse of 100-110; Not having an appetite; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Not having an appetite), PALPITATIONS (Fast heart beat/Pulse of 100-110), COVID-19 (Covid symptoms), DIARRHOEA (Diarrhea) and VACCINATION SITE RASH (Red rash) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in March 2021.    On 25-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced PALPITATIONS (Fast heart beat/Pulse of 100-110) and PYREXIA (Fever of 101.6). On 27-Jan-2021, the patient experienced VACCINATION SITE RASH (Red rash). On 28-Jan-2021, the patient experienced COVID-19 (Covid symptoms) and DIARRHOEA (Diarrhea). On an unknown date, the patient experienced DECREASED APPETITE (Not having an appetite). On 28-Jan-2021, VACCINATION SITE RASH (Red rash) outcome was unknown. On 01-Feb-2021, COVID-19 (Covid symptoms) outcome was unknown. At the time of the report, DECREASED APPETITE (Not having an appetite) had resolved, PALPITATIONS (Fast heart beat/Pulse of 100-110) had not resolved and DIARRHOEA (Diarrhea) and PYREXIA (Fever of 101.6) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, Heart rate: 100-110 (abnormal) 100-110. On 25-Jan-2021, Pyrexia: 101.6 (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site rash
Clinical narrative: Covid symptoms; Diarrhea; Red rash; Fever of 101.6; Fast heart beat/Pulse of 100-110; Not having an appetite; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Not having an appetite), PALPITATIONS (Fast heart beat/Pulse of 100-110), COVID-19 (Covid symptoms), DIARRHOEA (Diarrhea) and VACCINATION SITE RASH (Red rash) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in March 2021.    On 25-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced PALPITATIONS (Fast heart beat/Pulse of 100-110) and PYREXIA (Fever of 101.6). On 27-Jan-2021, the patient experienced VACCINATION SITE RASH (Red rash). On 28-Jan-2021, the patient experienced COVID-19 (Covid symptoms) and DIARRHOEA (Diarrhea). On an unknown date, the patient experienced DECREASED APPETITE (Not having an appetite). On 28-Jan-2021, VACCINATION SITE RASH (Red rash) outcome was unknown. On 01-Feb-2021, COVID-19 (Covid symptoms) outcome was unknown. At the time of the report, DECREASED APPETITE (Not having an appetite) had resolved, PALPITATIONS (Fast heart beat/Pulse of 100-110) had not resolved and DIARRHOEA (Diarrhea) and PYREXIA (Fever of 101.6) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, Heart rate: 100-110 (abnormal) 100-110. On 25-Jan-2021, Pyrexia: 101.6 (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Feeling hot, Insomnia
Clinical narrative: Patient feels weak; He lost appetite; He can't sleep; He feels hot in the face; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Patient feels weak), DECREASED APPETITE (He lost appetite), INSOMNIA (He can't sleep) and FEELING HOT (He feels hot in the face) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced ASTHENIA (Patient feels weak), DECREASED APPETITE (He lost appetite), INSOMNIA (He can't sleep) and FEELING HOT (He feels hot in the face). At the time of the report, ASTHENIA (Patient feels weak), DECREASED APPETITE (He lost appetite), INSOMNIA (He can't sleep) and FEELING HOT (He feels hot in the face) had resolved. Not Provided          The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.  Patient was feeling fine now.    Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Event outcomes were updated
Sex: U
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: Body aches; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches) and HEADACHE (Headaches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (Body aches) and HEADACHE (Headaches). At the time of the report, MYALGIA (Body aches) and HEADACHE (Headaches) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.